Ernexa Therapeutics Inc.: Form 8-K, filed Dec 6, 2022
Filed with the SEC on Dec 6, 2022 and accepted by EDGAR at Dec 6, 2022, 16:30 ET.
Items reported
- Item 1.02 Termination of a material agreement
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-22-044598. Last ingested by Listed: Oct 30, 2026, 14:05 ET. Listed shows no prices and gives no investment advice.